• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.27% Nasdaq Up0.70%

    More On TSPT

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Transcept Pharmaceuticals, Inc. (TSPT)

    -NasdaqGM
    1.71 Down 0.03(1.72%) Oct 30 - Nasdaq Real Time Price
    Add to Portfolio
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):N/A
    Mean Recommendation (last week):N/A
    Change:N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:N/A
    Median Target:N/A
    High Target:N/A
    Low Target:N/A
    No. of Brokers:N/A

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    May 10, 2013MLV & CoDowngradeBuyHold
    Nov 1, 2011MLV CapitalUpgradeHoldBuy
    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy
    Buy
    Hold
    Underperform
    Sell

    Data provided by Thomson/First Call


    Currency in USD.